Slideshow

Antipsychotics and Cardiometabolic Risk: New Study Sheds Light

Antipsychotic medications may not cause type 2 diabetes but a new review find the drugs may accelerate development of the disease. How can you protect your patients?

References:1. Whicher CA, Price HC, Holt RIG, et al. Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation. Eur J Endocrinol. 2018;178:R245-R258.2. National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. https://www.nice.org.uk/Guidance/CG155. Published January 2013. Accessed July 17, 2018. 

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2024 MJH Life Sciences

All rights reserved.